Comparison of single versus double dose of recombinant human chorionic gonadotropin on final oocyte maturation in IVF cycles
Not Applicable
- Conditions
- Health Condition 1: N979- Female infertility, unspecified
- Registration Number
- CTRI/2024/04/065398
- Lead Sponsor
- Amrita Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All women between the age group of 21–40 years with normal or poor ovarian reserve undergoing IVF ET by Long Agonist Protocol.
Exclusion Criteria
History of OHSS
High basal ovarian reserve (AMH more than 8ng/ml or AFC more than 24)
Hyper response (more than 18 follicles of diameter 11mm or more)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method